{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:22:53Z","timestamp":1783549373710,"version":"3.55.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1097\/md.0000000000008426","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T22:01:19Z","timestamp":1509573679000},"page":"e8426","source":"Crossref","is-referenced-by-count":38,"title":["Primary hypothyroidism and isolated ACTH deficiency induced by nivolumab therapy"],"prefix":"10.1097","volume":"96","author":[{"given":"Mei Fang","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Ying","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Nuo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Long","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-31-20210226","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/phar.1643","article-title":"Immune checkpoint inhibitors: new insights and current place in cancer therapy","volume":"35","author":"La-Beck","year":"2015","journal-title":"Pharmacotherapy"},{"key":"R2-31-20210226","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/1758834016679942","article-title":"Nivolumab in renal cell carcinoma: latest evidence and clinical potential","volume":"9","author":"Mazza","year":"2017","journal-title":"Ther Adv Med Oncol"},{"key":"R3-31-20210226","doi-asserted-by":"crossref","first-page":"988","DOI":"10.4158\/EP12280.GL","article-title":"Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association","volume":"18","author":"Garber","year":"2012","journal-title":"Endocr Pract"},{"key":"R4-31-20210226","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11102-006-0408-5","article-title":"Isolated corticotrophin deficiency","volume":"9","author":"Andrioli","year":"2006","journal-title":"Pituitary"},{"key":"R5-31-20210226","doi-asserted-by":"crossref","first-page":"8910","DOI":"10.18632\/oncotarget.13315","article-title":"Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials","volume":"8","author":"Costa","year":"2017","journal-title":"Oncotarget"},{"key":"R6-31-20210226","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2217\/imt-2016-0147","article-title":"Risk of endocrine adverse events in cancer patients treated with PD-1 inhibitors: a systematic review and meta-analysis","volume":"9","author":"Shang","year":"2017","journal-title":"Immunotherapy"},{"key":"R8-31-20210226","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1111\/1346-8138.13797","article-title":"Hypopituitarism and hypothyroidism following atrioventricular block during nivolumab treatment","volume":"44","author":"Oda","year":"2017","journal-title":"J Dermatol"},{"key":"R9-31-20210226","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1210\/jcem-50-1-52","article-title":"Significance of thyrotropin excess in untreated primary adrenal insufficiency","volume":"50","author":"Topliss","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-31-20210226","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.autrev.2014.01.007","article-title":"Hashimoto thyroiditis: clinical and diagnostic criteria","volume":"13","author":"Caturegli","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R11-31-20210226","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ecl.2014.10.011","article-title":"Hypophysitis","volume":"44","author":"Fukuoka","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R12-31-20210226","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1507\/endocrj.EJ16-0161","article-title":"Nivolumab-induced hypophysitis in a patient with advanced malignant melanoma","volume":"63","author":"Okano","year":"2016","journal-title":"Endocr J"},{"key":"R13-31-20210226","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/1346-8138.13437","article-title":"Case of hypophysitis caused by nivolumab","volume":"44","author":"Ishikawa","year":"2017","journal-title":"J Dermatol"},{"key":"R14-31-20210226","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1507\/endocrj.EJ16-0596","article-title":"Hyponatremia can be a powerful predictor of the development of isolated ACTH deficiency associated with nivolumab treatment [Letter to the Editor]","volume":"64","author":"Cho","year":"2017","journal-title":"Endocr J"},{"key":"R15-31-20210226","first-page":"4","article-title":"Isolated ACTH deficiency probably induced by autoimmune-related mechanism evoked with nivolumab.","volume":"1-","author":"Kitajima","year":"2017","journal-title":"Jpn J Clin Oncol"},{"key":"R16-31-20210226","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1089\/thy.2016.0562","article-title":"Clinical features of nivolumab-induced thyroiditis: a case series study","volume":"27","author":"Yamauchi","year":"2017","journal-title":"Thyroid"},{"key":"R17-31-20210226","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/0891693031000095871","article-title":"Autoimmunity as the most frequent cause of idiopathic secondary adrenal insufficiency: report of 111 cases","volume":"36","author":"Kasperlik-Zaluska","year":"2003","journal-title":"Autoimmunity"},{"key":"R18-31-20210226","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s11102-008-0164-9","article-title":"Isolated acquired ACTH deficiency and primary hypothyroidism: a short series and review","volume":"14","author":"Hannon","year":"2011","journal-title":"Pituitary"},{"key":"R19-31-20210226","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an Endocrine Society Clinical Practice Guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-31-20210226","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrendo.2016.205","article-title":"Cancer immunotherapy: immune checkpoint blockade and associated endocrinopathies","volume":"13","author":"Byun","year":"2017","journal-title":"Nat Rev Endocrinol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008426","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:38:17Z","timestamp":1620959897000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201711030-00031"}},"subtitle":["Case report and review"],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":19,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008426","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}